Previous Article | Next Article ![]()
Infection and Immunity, October 2003, p. 6058-6062, Vol. 71, No. 10
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.10.6058-6062.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Max-Planck-Institut für Immunbiologie, 79108 Freiburg,1 Institute for Medical Microbiology, Immunology, and Hygiene, Technische Universität München, Munich, Germany,2 Institute of Anatomy, Faculty of Medicine,3 Department of Clinical Medicine, Immunology and Infectious Diseases, Faculty of Medicine, University of Bari, Policlinico, 70124 Bari, Italy4
Received 6 March 2003/ Returned for modification 5 April 2003/ Accepted 14 July 2003
| ABSTRACT |
|---|
|
|
|---|
| TEXT |
|---|
|
|
|---|
) mediated (8, 16). Hypersensitive mice overproduce tumor necrosis factor alpha (TNF-
) and interleukin-6 (IL-6) upon challenge and exhibit an enhanced susceptibility to the lethal activity of LPS, LP, and TNF-
. Priming with P. acnes also induces a weak, IFN-
-independent sensitization to Staphylococcus aureus and to components of gram-negative bacteria other than LPS (20).
In this study, we analyzed the relative contributions of TLR2 and TLR4 to the bacterial induction of IL-6 and TNF-
in macrophages in vitro and in unsensitized and P. acnes-sensitized mice in vivo, using C57BL/10 animals deficient in TLR2, TLR4, or both. Wild-type C57BL/10ScSn and C57BL/6 mice and TLR4-deficient C57BL/10ScN (21, 29) mice were bred in the animal facilities of the Max-Planck-Institut. TLR2-deficient mice (30), provided by Tularik, Inc., South San Francisco, Calif., were backcrossed six times to either C57BL/10ScSn mice to obtain TLR2 single-deficient mice or to C57BL/10ScN mice to obtain TLR2/TLR4 double-deficient mice. MyD88-deficient mice (1) were provided by S. Akira (Research Institute for Microbial Diseases, Osaka, Japan). Heat-killed Salmonella enterica serovar Typhimurium and P. acnes (strain ATCC 12930) were prepared as described previously (25). A laboratory strain of S. aureus and two fresh clinical isolates of methicillin-sensitive S. aureus, provided by K. Pelz and R. Engelhardt (Institute for Medical Microbiology and Hygiene, Freiburg, Germany), were used. The bacteria were grown overnight in Trypticase soy broth (Difco Laboratories, Detroit, Mich.) at 37°C and then washed and heat killed (56°C for 1 h).
IL-6 and TNF-
responses served as a measure of macrophage sensitivity to the bacterial agents used. Mouse macrophages obtained in vitro from bone marrow precursors (7) were stimulated in triplicate with graded amounts of bacterial components or whole bacteria (in 10 µl per well), and culture supernatants were collected 4 and 24 h later for TNF-
and IL-6 measurements, respectively. TNF-
in cell supernatants was measured with a bioassay (2, 6), and IL-6 was measured with an enzyme-linked immunosorbent assay (PharMingen, San Diego, Calif.). Figures 1 and 2 show the results obtained with macrophages from wild-type and TLR2- and TLR4-deficient mice stimulated with different agents. There was a strict requirement for TLR4 and TLR2 in the responses of the macrophages to LPS and LP, respectively (Fig. 1). As expected, LPS of S. enterica serovar Typhimurium (12) induced dose-dependent IL-6 and TNF-
responses (Fig. 1, left) only in wild-type and TLR2-deficient macrophages, while LP (Pam3Cys-Ser-Lys4; EMC Microcollections GmbH, Tübingen, Germany) induced such responses only in wild-type and TLR4-deficient cells (Fig. 1, right).
|
|
response and abolished the IL-6 response completely. Results similar to these were also obtained with heat-killed Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, Pseudomonas saccharophila, S. enterica serovar Minnesota S form, S. enterica serovar Minnesota R595 (Re), S. enterica serovar Typhi, and S. enterica serovar Enteritidis (data not shown). Thus, LPS plays a dominant role in the cytokine response of macrophages to gram-negative bacteria. Furthermore, almost the entire cytokine-inducing activity of gram-negative bacteria in macrophages is TLR4 and TLR2 dependent.
The IL-6 and TNF-
responses of the different types of macrophages to S. aureus were not significantly different, regardless of the presence or absence of TLR2 or TLR4, (Fig. 2). This was true for different experiments in which a laboratory strain and two fresh clinical isolates of S. aureus were used. This indicates that the activation of macrophages by S. aureus is independent of TLR2 and TLR4.
To the contrary, in a previous study (27), TLR2-deficient macrophages produced reduced amounts of TNF-
and IL-6 in response to heat-killed S. aureus. Of note, in the study described above, different type of macrophages were used, only a single dose of bacteria was examined, and there was no information about whether the TLR2-deficient mice used were backcrossed to a defined background. However, that study also indicated the involvement of an additional signaling receptor(s) in the response to S. aureus.
MyD88 is an important adapter protein common to signaling pathways via members of TLR family (17). We therefore examined the responsiveness of MyD88-deficient and wild-type macrophages to S. aureus. As shown in Fig. 3, the absence of MyD88 completely abolished the IL-6 and TNF-
responses of macrophages to S. aureus. This shows, in agreement with previous results (27), that a MyD88-dependent signaling pathway is essential for the recognition of S. aureus and suggests the involvement of a TLR distinct from TLR2 and TLR4.
|
and IL-6 responses were determined in plasma collected 1 and 2 h after challenge. In unsensitized mice, the absence of TLR4 substantially reduced the cytokine response to S. typhimurium (Fig. 4). An additional absence of TLR2 in TLR2/TLR4 double-deficient mice lowered this response further (P values for comparison of TNF-
response of TLR4-deficient to TLR2/TLR4 double-deficient mice: 15 µg/g, 0.024; 3 µg/g, 0.002; and 0.6 µg/g, 0.0096). Generally, P. acnes-sensitized mice challenged with S. enterica serovar Typhimurium produced higher cytokine levels than the respective unsensitized animals (Fig. 4). The absence of TLR2 alone had no effect on the enhanced responses to S. enterica serovar Typhimurium, while the absence of TLR4 substantially reduced these responses. Furthermore, the combined deficiency of both TLRs resulted in an extensive loss of responsiveness. Altogether, the results obtained in vivo and in vitro show that the cytokine responses to gram-negative pathogens are dependent predominantly on TLR4 and, to a much lesser extent, on TLR2. The identities of the TLR2-dependent ligand or ligands of gram-negative bacteria were not addressed here, but lipoproteins are likely candidates (3, 33). The secondary role of TLR2 may be explained by a low concentration or little accessibility (31) of the respective ligands in bacteria. Alternatively, the signal transduction efficacy of the TLR2 in bone marrow-derived macrophages may be lower than that of TLR4. The finding that the synthetic LP was less efficient than LPS in inducing cytokines in macrophages supports this idea.
|
S. aureus (Fig. 5) was a much weaker inducer of TNF-
and IL-6 than S. enterica serovar Typhimurium (Fig. 4) in P. acnes-primed and unprimed mice, respectively. Furthermore, the responses of primed and unprimed TLR2-, TLR4-, and TLR2/TLR4 double-deficient mice were not reduced (Fig. 5), indicating that the latter were neither TLR2 nor TLR4 dependent. TLR2-independent cytokine induction by S. aureus is also strongly suggested by the weak activity of S. aureus in P. acnes-primed mice. As shown previously, P. acnes priming strongly enhances TLR2-mediated cytokine responses by 2 orders of magnitude (20).
|
and IL-6 by S. aureus. Consequently, TLR2-dependent components such as PGN and LTA are not involved in this effect. An attempt to identify the receptor in question by using HEK293 cells ectopically expressing one or more different TLRs (TLR1 to -9) together with CD14 and MD-2 so far has been unsuccessful (data not shown). However, a possible lack of unknown coreceptor molecules in HEK293 cells might have been responsible. Further investigations are required to identify the receptors involved in the cytokine responses of S. aureus.
| ACKNOWLEDGMENTS |
|---|
This study was partly supported by DFG, SP "Angeborene Immunität" (FR 448/4-1).
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150.[CrossRef][Medline] |
| 2. | Aggarwal, B. B., W. J. Kohr, P. E. Hass, B. Moffat, S. A. Spencer, W. J. Henzel, T. S. Bringman, G. E. Nedwin, D. V. Goeddel, and R. N. Harkins. 1985. Human tumor necrosis factor. Production, purification, and characterization. J. Biol. Chem. 260:2345-2354. |
| 3. | Aliprantis, A. O., D. S. Weiss, J. D. Radolf, and A. Zychlinsky. 2001. Release of Toll-like receptor-2-activating bacterial lipoproteins in Shigella flexneri culture supernatants. Infect. Immun. 69:6248-6255. |
| 4. | Aliprantis, A. O., R. B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285:736-739. |
| 5. | Beutler, B., X. Du, and A. Poltorak. 2001. Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies. J. Endotoxin Res. 7:277-280.[CrossRef][Medline] |
| 6. | Freudenberg, M. A., and C. Galanos. 1991. Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect. Immun. 59:2110-2115. |
| 7. | Freudenberg, M. A., D. Keppler, and C. Galanos. 1986. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect. Immun. 51:891-895. |
| 8. | Freudenberg, M. A., M. Kopf, and C. Galanos. 1996. Lipopolysaccharide-sensitivity of interferon-gamma-receptor deficient mice. J. Endotoxin. Res. 3:291-295. |
| 9. | Freudenberg, M. A., T. Merlin, M. Gumenscheimer, C. Kalis, R. Landmann, and C. Galanos. 2001. Role of lipopolysaccharide susceptibility in the innate immune response to Salmonella typhimurium infection: LPS, a primary target for recognition of Gram-negative bacteria. Microbes Infect. 3:1213-1222.[CrossRef][Medline] |
| 10. | Galanos, C., M. A. Freudenberg, M. Matsuura, and A. Coumbos. 1988. Hypersensitivity to endotoxin and mechanisms of host-response. Prog. Clin. Biol. Res. 272:295-308.[Medline] |
| 11. | Galanos, C., M. Gumenscheimer, P. Muhlradt, E. Jirillo, and M. Freudenberg. 2000. MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly? J. Endotoxin Res. 6:471-476.[CrossRef][Medline] |
| 12. | Galanos, C., O. Luderitz, and O. Westphal. 1979. Preparation and properties of a standardized lipopolysaccharide from Salmonella abortus equi (Novo-Pyrexal). Zentbl. Bakteriol. Orig A 243:226-244. |
| 13. | Halpern, B. N., A.-R. Prévot, G. Biozzi, C. Stifel, D. Mouton, J. C. Morard, Y. Bouthillier, and C. Decreusefond. 1964. Stimulation de l'activité phagocytaire du systéme réticuloendothélial provoquée par Corynebacterium parvum RES. J. Reticuloendothel. Soc. 1:77-96. |
| 14. | Janeway, C. A., Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54:1-13. |
| 15. | Kalis, C., B. Kanzler, A. Lembo, A. Poltorak, C. Galanos, and M. A. Freudenberg. 2003. Toll-like receptor 4 expression levels determine the degree of LPS-susceptibility in mice. Eur. J. Immunol. 33:798-805.[CrossRef][Medline] |
| 16. | Katschinski, T., C. Galanos, A. Coumbos, and M. A. Freudenberg. 1992. Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect. Immun. 60:1994-2001. |
| 17. | Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115-122.[CrossRef][Medline] |
| 18. | Laskin, D. L., B. Weinberger, and J. D. Laskin. 2001. Functional heterogeneity in liver and lung macrophages. J. Leukoc. Biol. 70:163-170. |
| 19. | Medzhitov, R., and C. A. Janeway, Jr. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91:295-298.[CrossRef][Medline] |
| 20. | Merlin, T., M. Gumenscheimer, C. Galanos, and M. A. Freudenberg. 2001. TNF-alpha hyper-responses to Gram-negative and Gram-positive bacteria in Propionibacterium acnes primed or Salmonella typhimurium infected mice. J. Endotoxin Res. 7:157-163.[CrossRef][Medline] |
| 21. | Merlin, T., A. Sing, P. J. Nielsen, C. Galanos, and M. A. Freudenberg. 2001. Inherited IL-12 unresponsiveness contributes to the high LPS resistance of the Lps(d) C57BL/10ScCr mouse. J. Immunol. 166:566-573. |
| 22. | Ozinsky, A., D. M. Underhill, J. D. Fontenot, A. M. Hajjar, K. D. Smith, C. B. Wilson, L. Schroeder, and A. Aderem. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. USA 97:13766-13771. |
| 23. | Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088. |
| 24. | Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274:17406-17409. |
| 25. | Sing, A., T. Merlin, H.-P. Knopf, P. J. Nielsen, H. Loppnow, C. Galanos, and M. A. Freudenberg. 2000. Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component. Infect. Immun. 68:1600-1607. |
| 26. | Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.[CrossRef][Medline] |
| 27. | Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392-5396. |
| 28. | Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451.[CrossRef][Medline] |
| 29. | Vogel, S. N., C. T. Hansen, and D. L. Rosenstreich. 1979. Characterization of a congenitally LPS-resistant, athymic mouse strain. J. Immunol. 122:619-622. |
| 30. | Werts, C., R. I. Tapping, J. C. Mathison, T. H. Chuang, V. Kravchenko, I. Saint Girons, D. A. Haake, P. J. Godowski, F. Hayashi, A. Ozinsky, D. M. Underhill, C. J. Kirschning, H. Wagner, A. Aderem, P. S. Tobias, and R. J. Ulevitch. 2001. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2:346-352.[CrossRef][Medline] |
| 31. | Wu, H. C. 1996. Biosynthesis of lipoproteins, p. 1005-1014. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella. Cellular and molecular biology, 2nd ed., vol. 1. ASM Press, Washington, D.C. |
| 32. | Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1-5. |
| 33. | Zhang, H., D. W. Niesel, J. W. Peterson, and G. R. Klimpel. 1998. Lipoprotein release by bacteria: potential factor in bacterial pathogenesis. Infect. Immun. 66:5196-5201. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|